FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:2083-2085 December 19, 2002 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Salvarani, C. PubMed Citation

To the Editor: The prognosis for patients with polymyalgia rheumatica and temporal arteritis may not be as benign as intimated by Salvarani et al. (July 25 issue).¹ Despite the rapid initial response to corticosteroids, treatment is usually required for at least two years in the majority of patients. Studies in the United States suggest a shorter duration of therapy, in contrast to the European experience; this difference may be a manifestation of variations in demographic characteristics, the selection of patients, or the study design. In a study in Sweden, only 24 percent of patients with polymyalgia rheumatica, 16 percent of . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.